Skip to content

Michael Jeltsch

  • Dr.
  • Group leader & Academy Research Fellow
  • Helsingin yliopisto - University of Helsinki
31

h-index

Impact measure calculated by Scopus using these publications and citation counts.
9089

Citations

Number of citations received by these publications in Scopus.

Research Interests

(Lymph)angiogenesis Protein production and purification Antibody technologies

Followers (8)

Explore network

Following (4)

About

2013 Group leader in the Translational Cancer Biology Program, University of Helsinki, Finland
2011 Habilitation (Proteinchemie), University of Helsinki, Finland
2002 PhD (Biochemistry), University of Helsinki, Finland
1997 MSc (Biochemistry), University of Helsinki, Finland
1992 BSc ("Vordiplom", Biochemie/Molekularbiologie), University of Hamburg, Germany
1989 Allgemeine Hochschulreife, Gymnasium An der Stenner, Iserlohn, Germany
July 28, 1969 Born in Hemer/NW, Germany

Publications

Die genetischen Ursachen des primären Lymphödems

Mattonet K, Wilting J, Jeltsch M

Erkrankungen des Lymphgefäßsystems (2015)

  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Functional dissection of the CCBE1 protein: A crucial requirement for the collagen repeat domain

Roukens M, Peterson-Maduro J, Padberg Y, Jeltsch M, Leppänen V, Bos F, Alitalo K, Schulte-Merker S, Schulte D

Circulation Research (2015)

  • Get full text at journal
  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Substrate efflux propensity is the key determinant of Ca<sup>2+</sup>-independent phospholipase A-β (iPLAβ)-mediated glycerophospholipid hydrolysis

Batchu K, Hokynar K, Jeltsch M, Mattonet K, Somerharju P

Journal of Biological Chemistry (2015)

  • Get full text at journal
  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Substrate efflux propensity is the key determinant of iPLA-β-mediated glycerophospholipid hydrolysis

Batchu K, Hokynar K, Jeltsch M, Mattonet K, Somerharju P

Journal of Biological Chemistry (2015)

  • Get full text at journal
  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

The TIE receptor family

Saharinen P, Jeltsch M, Santoyo M, Leppänen V, Alitalo K

Receptor Tyrosine Kinases: Family and Subfamilies (2015)

  • Get full text at journal
  • -- Readers Readers not available. This publication is not currently accessible in the Mendeley catalog.

Professional experience

Group leader & Academy Research Fellow

Helsingin yliopisto - University of Helsinki

September 2013 - Present

Postdoctoral Fellow

Wihuri Research Institute

January 2013 - August 2013 (7 months)

graduate student, postgraduate student, postdoc

Molecular/Cancer Biology Lab, University of Helsinki

May 1996 - August 2013 (17 years 3 months)

Researcher

Circadian Technologies via Vegenics Ltd. via Licentia Ltd.

February 2007 - December 2011 (4 years 10 months)

Researcher

Lymphatix Ltd. (now Ark Therapeutics) via Licentia Ltd.

April 2006 - January 2007 (9 months)

Studentische Hilfskraft

Heinrich-Pette-Institut für Experimentelle Virologie und Immunologie an der Universität Hamburg

August 1993 - July 1994 (11 months)